Listed

Edwards Lifesciences Corp

EWNYSECIK 1099800HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.74bn, Q2 FY2026
Operating income$513.2m, Q2 FY2026
Net income$241.9m, Q2 FY2026
Edwards Lifesciences Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1,243Revenue, Q3 FY2023, three months to 2023-09-30$1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,266Revenue, Q4 FY2023, three months to 2023-12-31$1.27bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,330Revenue, Q1 FY2024, three months to 2024-03-31$1.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure1,369Revenue, Q2 FY2024, three months to 2024-06-30$1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure1,354Revenue, Q3 FY2024, three months to 2024-09-30$1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure1,386Revenue, Q4 FY2024, three months to 2024-12-31$1.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,413Revenue, Q1 FY2025, three months to 2025-03-31$1.41bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure1,532Revenue, Q2 FY2025, three months to 2025-06-30$1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure1,553Revenue, Q3 FY2025, three months to 2025-09-30$1.55bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure1,570Revenue, Q4 FY2025, three months to 2025-12-31$1.57bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1,649Revenue, Q1 FY2026, three months to 2026-03-31$1.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure1,741Revenue, Q2 FY2026, three months to 2026-06-30$1.74bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Cost of revenue$m251Cost of revenue, Q3 FY2023, three months to 2023-09-30$250.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure251Cost of revenue, Q4 FY2023, three months to 2023-12-31$251.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure287Cost of revenue, Q1 FY2024, three months to 2024-03-31$286.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure276Cost of revenue, Q2 FY2024, three months to 2024-06-30$275.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure263Cost of revenue, Q3 FY2024, three months to 2024-09-30$262.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure292Cost of revenue, Q4 FY2024, three months to 2024-12-31$292.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure302Cost of revenue, Q1 FY2025, three months to 2025-03-31$301.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure344Cost of revenue, Q2 FY2025, three months to 2025-06-30$344.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure345Cost of revenue, Q3 FY2025, three months to 2025-09-30$345.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure343Cost of revenue, Q4 FY2025, three months to 2025-12-31$343.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure363Cost of revenue, Q1 FY2026, three months to 2026-03-31$362.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure392Cost of revenue, Q2 FY2026, three months to 2026-06-30$392.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Gross profit$m993Gross profit, Q3 FY2023, three months to 2023-09-30$992.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,015Gross profit, Q4 FY2023, three months to 2023-12-31$1.02bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,043Gross profit, Q1 FY2024, three months to 2024-03-31$1.04bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure1,094Gross profit, Q2 FY2024, three months to 2024-06-30$1.09bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure1,092Gross profit, Q3 FY2024, three months to 2024-09-30$1.09bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure1,094Gross profit, Q4 FY2024, three months to 2024-12-31$1.09bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1,111Gross profit, Q1 FY2025, three months to 2025-03-31$1.11bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure1,188Gross profit, Q2 FY2025, three months to 2025-06-30$1.19bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure1,208Gross profit, Q3 FY2025, three months to 2025-09-30$1.21bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure1,227Gross profit, Q4 FY2025, three months to 2025-12-31$1.23bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1,286Gross profit, Q1 FY2026, three months to 2026-03-31$1.29bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure1,349Gross profit, Q2 FY2026, three months to 2026-06-30$1.35bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Research and development$m243Research and development, Q3 FY2023, three months to 2023-09-30$242.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure242Research and development, Q4 FY2023, three months to 2023-12-31$242.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure257Research and development, Q1 FY2024, three months to 2024-03-31$256.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure272Research and development, Q2 FY2024, three months to 2024-06-30$271.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure253Research and development, Q3 FY2024, three months to 2024-09-30$253.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure271Research and development, Q4 FY2024, three months to 2024-12-31$271.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure255Research and development, Q1 FY2025, three months to 2025-03-31$254.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure276Research and development, Q2 FY2025, three months to 2025-06-30$276.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure281Research and development, Q3 FY2025, three months to 2025-09-30$280.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure268Research and development, Q4 FY2025, three months to 2025-12-31$267.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure263Research and development, Q1 FY2026, three months to 2026-03-31$263.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure279Research and development, Q2 FY2026, three months to 2026-06-30$278.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Selling, general and administrative$m382Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$381.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure417Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$416.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure428Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$428.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure448Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$447.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure421Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$421.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure492Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$491.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure466Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$465.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure502Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$502.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure515Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$514.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure603Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$602.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure522Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$522.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure561Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$561.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Operating income$m366Operating income, Q3 FY2023, three months to 2023-09-30$365.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure347Operating income, Q4 FY2023, three months to 2023-12-31$346.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure349Operating income, Q1 FY2024, three months to 2024-03-31$349.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure367Operating income, Q2 FY2024, three months to 2024-06-30$366.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure351Operating income, Q3 FY2024, three months to 2024-09-30$350.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure313Operating income, Q4 FY2024, three months to 2024-12-31$312.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure395Operating income, Q1 FY2025, three months to 2025-03-31$394.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure411Operating income, Q2 FY2025, three months to 2025-06-30$411.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure307Operating income, Q3 FY2025, three months to 2025-09-30$307.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure151Operating income, Q4 FY2025, three months to 2025-12-31$151.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure478Operating income, Q1 FY2026, three months to 2026-03-31$477.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure513Operating income, Q2 FY2026, three months to 2026-06-30$513.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m52.7Income tax, Q3 FY2023, three months to 2023-09-30$52.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure34.1Income tax, Q4 FY2023, three months to 2023-12-31$34.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure46.3Income tax, Q1 FY2024, three months to 2024-03-31$46.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure20.0Income tax, Q2 FY2024, three months to 2024-06-30$20.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure40.7Income tax, Q3 FY2024, three months to 2024-09-30$40.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure45.1Income tax, Q4 FY2024, three months to 2024-12-31$45.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure70.3Income tax, Q1 FY2025, three months to 2025-03-31$70.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure64.3Income tax, Q2 FY2025, three months to 2025-06-30$64.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure56.1Income tax, Q3 FY2025, three months to 2025-09-30$56.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure26.2Income tax, Q4 FY2025, three months to 2025-12-31$26.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure78.3Income tax, Q1 FY2026, three months to 2026-03-31$78.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure278Income tax, Q2 FY2026, three months to 2026-06-30$278.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Net income$m385Net income, Q3 FY2023, three months to 2023-09-30$384.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure370Net income, Q4 FY2023, three months to 2023-12-31$369.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure352Net income, Q1 FY2024, three months to 2024-03-31$351.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure366Net income, Q2 FY2024, three months to 2024-06-30$366.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure3,071Net income, Q3 FY2024, three months to 2024-09-30$3.07bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure386Net income, Q4 FY2024, three months to 2024-12-31$385.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure358Net income, Q1 FY2025, three months to 2025-03-31$358.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure333Net income, Q2 FY2025, three months to 2025-06-30$333.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure291Net income, Q3 FY2025, three months to 2025-09-30$291.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure91.2Net income, Q4 FY2025, three months to 2025-12-31$91.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure381Net income, Q1 FY2026, three months to 2026-03-31$380.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure242Net income, Q2 FY2026, three months to 2026-06-30$241.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Diluted EPS$ per share0.63Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.61Diluted EPS, Q4 FY2023, three months to 2023-12-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.58Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure0.61Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure5.13Diluted EPS, Q3 FY2024, three months to 2024-09-30$5.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure0.65Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.61Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure0.56Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure0.50Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figurenot reported0.66Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure0.42Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Basic EPS$ per share0.63Basic EPS, Q3 FY2023, three months to 2023-09-30$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.61Basic EPS, Q4 FY2023, three months to 2023-12-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.58Basic EPS, Q1 FY2024, three months to 2024-03-31$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure0.61Basic EPS, Q2 FY2024, three months to 2024-06-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure5.14Basic EPS, Q3 FY2024, three months to 2024-09-30$5.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure0.65Basic EPS, Q4 FY2024, three months to 2024-12-31$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.61Basic EPS, Q1 FY2025, three months to 2025-03-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure0.57Basic EPS, Q2 FY2025, three months to 2025-06-30$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure0.50Basic EPS, Q3 FY2025, three months to 2025-09-30$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figurenot reported0.66Basic EPS, Q1 FY2026, three months to 2026-03-31$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure0.42Basic EPS, Q2 FY2026, three months to 2026-06-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure

Balance sheet

Cash and equivalents$2.91bn, Q2 FY2026
Long-term debt$598.7m, Q2 FY2026
Shareholders' equity$10.62bn, Q2 FY2026
Edwards Lifesciences Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn1.4Cash and equivalents, Q3 FY2023, at 2023-09-30$1.41bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure1.1Cash and equivalents, FY2023, at 2023-12-31$1.13bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1.2Cash and equivalents, Q1 FY2024, at 2024-03-31$1.22bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure1.6Cash and equivalents, Q2 FY2024, at 2024-06-30$1.64bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure3.7Cash and equivalents, Q3 FY2024, at 2024-09-30$3.68bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure3.0Cash and equivalents, FY2024, at 2024-12-31$3.05bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure3.1Cash and equivalents, Q1 FY2025, at 2025-03-31$3.14bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure3.3Cash and equivalents, Q2 FY2025, at 2025-06-30$3.27bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure2.7Cash and equivalents, Q3 FY2025, at 2025-09-30$2.69bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure2.9Cash and equivalents, FY2025, at 2025-12-31$2.94bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure2.4Cash and equivalents, Q1 FY2026, at 2026-03-31$2.45bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure2.9Cash and equivalents, Q2 FY2026, at 2026-06-30$2.91bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Current assets$bn4.1Current assets, Q3 FY2023, at 2023-09-30$4.07bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure4.0Current assets, FY2023, at 2023-12-31$4.04bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure4.2Current assets, Q1 FY2024, at 2024-03-31$4.17bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure4.5Current assets, Q2 FY2024, at 2024-06-30$4.52bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure6.7Current assets, Q3 FY2024, at 2024-09-30$6.73bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure6.3Current assets, FY2024, at 2024-12-31$6.29bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure6.2Current assets, Q1 FY2025, at 2025-03-31$6.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure6.6Current assets, Q2 FY2025, at 2025-06-30$6.58bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure6.4Current assets, Q3 FY2025, at 2025-09-30$6.36bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure6.7Current assets, FY2025, at 2025-12-31$6.74bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure6.2Current assets, Q1 FY2026, at 2026-03-31$6.23bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure6.8Current assets, Q2 FY2026, at 2026-06-30$6.82bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Total assets$bn9.4Total assets, Q3 FY2023, at 2023-09-30$9.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure9.4Total assets, FY2023, at 2023-12-31$9.36bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure9.7Total assets, Q1 FY2024, at 2024-03-31$9.74bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure10.1Total assets, Q2 FY2024, at 2024-06-30$10.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure13.0Total assets, Q3 FY2024, at 2024-09-30$12.97bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure13.1Total assets, FY2024, at 2024-12-31$13.06bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure13.0Total assets, Q1 FY2025, at 2025-03-31$13.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure13.5Total assets, Q2 FY2025, at 2025-06-30$13.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure13.3Total assets, Q3 FY2025, at 2025-09-30$13.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure13.7Total assets, FY2025, at 2025-12-31$13.70bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure13.3Total assets, Q1 FY2026, at 2026-03-31$13.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure13.9Total assets, Q2 FY2026, at 2026-06-30$13.87bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Current liabilities$bn1.2Current liabilities, Q3 FY2023, at 2023-09-30$1.24bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure1.2Current liabilities, FY2023, at 2023-12-31$1.20bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure1.1Current liabilities, Q1 FY2024, at 2024-03-31$1.11bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure1.2Current liabilities, Q2 FY2024, at 2024-06-30$1.22bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure1.9Current liabilities, Q3 FY2024, at 2024-09-30$1.94bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure1.5Current liabilities, FY2024, at 2024-12-31$1.51bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure1.4Current liabilities, Q1 FY2025, at 2025-03-31$1.39bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure1.4Current liabilities, Q2 FY2025, at 2025-06-30$1.40bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure1.6Current liabilities, Q3 FY2025, at 2025-09-30$1.59bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure1.8Current liabilities, FY2025, at 2025-12-31$1.81bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure1.4Current liabilities, Q1 FY2026, at 2026-03-31$1.41bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure1.5Current liabilities, Q2 FY2026, at 2026-06-30$1.51bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Total liabilities$bn2.6Total liabilities, Q3 FY2023, at 2023-09-30$2.64bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure2.6Total liabilities, FY2023, at 2023-12-31$2.64bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure2.5Total liabilities, Q1 FY2024, at 2024-03-31$2.55bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure2.6Total liabilities, Q2 FY2024, at 2024-06-30$2.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure3.4Total liabilities, Q3 FY2024, at 2024-09-30$3.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure3.0Total liabilities, FY2024, at 2024-12-31$2.99bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure2.8Total liabilities, Q1 FY2025, at 2025-03-31$2.83bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure2.9Total liabilities, Q2 FY2025, at 2025-06-30$2.88bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure3.1Total liabilities, Q3 FY2025, at 2025-09-30$3.07bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure3.4Total liabilities, FY2025, at 2025-12-31$3.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure3.0Total liabilities, Q1 FY2026, at 2026-03-31$2.99bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure3.1Total liabilities, Q2 FY2026, at 2026-06-30$3.14bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Long-term debt$bn0.6Long-term debt, Q3 FY2023, at 2023-09-30$596.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure0.6Long-term debt, FY2023, at 2023-12-31$597.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure0.6Long-term debt, Q1 FY2024, at 2024-03-31$597.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure0.6Long-term debt, Q2 FY2024, at 2024-06-30$597.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure0.6Long-term debt, Q3 FY2024, at 2024-09-30$597.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure0.6Long-term debt, FY2024, at 2024-12-31$597.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure0.6Long-term debt, Q1 FY2025, at 2025-03-31$597.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure0.6Long-term debt, Q2 FY2025, at 2025-06-30$598.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure0.6Long-term debt, Q3 FY2025, at 2025-09-30$598.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure0.6Long-term debt, FY2025, at 2025-12-31$598.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure0.6Long-term debt, Q1 FY2026, at 2026-03-31$598.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure0.6Long-term debt, Q2 FY2026, at 2026-06-30$598.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure
Current portion of debt$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$bn6.7Shareholders' equity, Q3 FY2023, at 2023-09-30$6.66bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure6.7Shareholders' equity, FY2023, at 2023-12-31$6.65bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-28, accession 0001099800-25-000005.Report this figure7.1Shareholders' equity, Q1 FY2024, at 2024-03-31$7.12bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure7.4Shareholders' equity, Q2 FY2024, at 2024-06-30$7.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure9.5Shareholders' equity, Q3 FY2024, at 2024-09-30$9.55bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure10.0Shareholders' equity, FY2024, at 2024-12-31$10.00bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001099800-26-000009.Report this figure10.1Shareholders' equity, Q1 FY2025, at 2025-03-31$10.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure10.5Shareholders' equity, Q2 FY2025, at 2025-06-30$10.55bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure10.2Shareholders' equity, Q3 FY2025, at 2025-09-30$10.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure10.3Shareholders' equity, FY2025, at 2025-12-31$10.34bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure10.3Shareholders' equity, Q1 FY2026, at 2026-03-31$10.33bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure10.6Shareholders' equity, Q2 FY2026, at 2026-06-30$10.62bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure

Cash flow

Operating cash flow$651.9m, Q2 FY2026
Capital expenditure$66.9m, Q2 FY2026
Share repurchases$153.3m, Q2 FY2026
Edwards Lifesciences Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m412Operating cash flow, Q3 FY2023, three months to 2023-09-30$411.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001099800-24-000086. Derived: 9-month figure less the 6-month figure.Report this figure137Operating cash flow, Q4 FY2023, three months to 2023-12-31$136.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(53.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$53.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure372Operating cash flow, Q2 FY2024, three months to 2024-06-30$371.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001099800-25-000048. Derived: 6-month figure less the 3-month figure.Report this figure352Operating cash flow, Q3 FY2024, three months to 2024-09-30$351.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure(128)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$127.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure280Operating cash flow, Q1 FY2025, three months to 2025-03-31$280.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure290Operating cash flow, Q2 FY2025, three months to 2025-06-30$290.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure574Operating cash flow, Q3 FY2025, three months to 2025-09-30$573.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure451Operating cash flow, Q4 FY2025, three months to 2025-12-31$450.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure43.8Operating cash flow, Q1 FY2026, three months to 2026-03-31$43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure652Operating cash flow, Q2 FY2026, three months to 2026-06-30$651.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m55.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$55.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001099800-24-000086. Derived: 9-month figure less the 6-month figure.Report this figure88.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$88.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure65.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$65.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure85.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$85.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001099800-25-000048. Derived: 6-month figure less the 3-month figure.Report this figure51.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$51.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure49.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$49.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure56.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$56.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure49.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$49.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure57.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$57.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure97.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$97.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure64.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$64.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure66.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$66.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m174Share repurchases, Q3 FY2023, three months to 2023-09-30$174.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-06, accession 0001099800-24-000086. Derived: 9-month figure less the 6-month figure.Report this figure448Share repurchases, Q4 FY2023, three months to 2023-12-31$448.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.2Share repurchases, Q1 FY2024, three months to 2024-03-31$200.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure158Share repurchases, Q2 FY2024, three months to 2024-06-30$158.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-06, accession 0001099800-25-000048. Derived: 6-month figure less the 3-month figure.Report this figure901Share repurchases, Q3 FY2024, three months to 2024-09-30$901.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure100Share repurchases, Q4 FY2024, three months to 2024-12-31$100.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure259Share repurchases, Q1 FY2025, three months to 2025-03-31$258.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure5.5Share repurchases, Q2 FY2025, three months to 2025-06-30$5.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure589Share repurchases, Q3 FY2025, three months to 2025-09-30$588.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0001099800-25-000062. Derived: 9-month figure less the 6-month figure.Report this figure40.6Share repurchases, Q4 FY2025, three months to 2025-12-31$40.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001099800-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure422Share repurchases, Q1 FY2026, three months to 2026-03-31$421.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure153Share repurchases, Q2 FY2026, three months to 2026-06-30$153.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0001099800-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)577.60m, Q2 FY2026
Edwards Lifesciences Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares625Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30624,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-27, accession 0001099800-23-000039.Report this figure611Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31610,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-29, accession 0001099800-24-000039.Report this figure610Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30610,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-31, accession 0001099800-24-000078.Report this figure610Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30609,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001099800-24-000086.Report this figure604Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31604,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001099800-25-000023.Report this figure604Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30604,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001099800-25-000048.Report this figure598Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30598,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure588Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31587,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure588Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30587,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure586Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30585,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001099800-25-000062.Report this figure581Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31580,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001099800-26-000026.Report this figure578Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30577,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure

Shares outstanding: 576.40mShares outstanding, period not labelled, at 2026-07-31576,400,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001099800-26-000043.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.